On Wednesday, April 23, from 14:00 p.m. to 15:00 p.m. (Argentine time), a open and free webinar, a virtual modality and with pre-registration, organized by the IECS Health Technology Assessment Consortium. At a key moment for the Argentine health system, in which the creation of a new national health technology assessment (HTA) agency is being discussed, the meeting's objective is to generate a space for reflection on the role of HTAs in coverage decision-making.
Based on specific cases, a pluralistic exchange will be proposed to advance toward fairer, more transparent, and evidence-based decisions.
Registration form: click here
Program:
- The creation of an Agency and the state of health technology assessment in Argentina today – Prof. Dr. Andrés Pichon-Riviere
- Four recent challenges in hedging decisions- Dr. Andrea Alcaraz
– Multiple indications, multiple options: SGLT inhibitors (empagliflozin, dapagliflozin, canagliflozin).
– Diagnostic methods in new health conditions: Breathalyzer test for SIBO.
– Emerging indications in new technologies: Pembrolizumab and Olaparib.
– High cost in rare diseases: Vosoritide in achondroplasia.
- The IECS Health Technology Assessment Consortium – Dr. Veronica Alfie
- How to move towards better decision-making processes? Dr. Federico Augustovski